Aclarion (ACONW) Debt to Equity (2023 - 2026)

Aclarion (ACONW) reported Debt to Equity of $0.0 for Q1 2026, down 53.35% quarter-over-quarter from $0.0 in Q4 2025.

Aclarion (ACONW) Debt to Equity (2023 - 2026) Analysis & Trends

Aclarion has reported Debt to Equity for 4 years, with the latest figure at $0.0 in Q1 2026.

For the quarter ending Q1 2026, Debt to Equity changed N/A year-over-year to $0.0; the trailing twelve-month figure through Mar 2026 stood at $0.0 (changed N/A YoY), and the FY2025 full-year result was $0.0, down 99.96% from the prior year.
Debt to Equity for Q1 2026 stood at $0.0, down from $0.0 in the prior quarter.
The five-year high for Debt to Equity was $16.86 in Q2 2023, with the low at -$0.44 in Q3 2023.
Historically, Debt to Equity has averaged $2.04 across 4 years, with a median of $0.01 in 2024.
Annual changes were most pronounced in 2024 — Debt to Equity soared 107.34% — and 2025, when it sank 99.96%.
Aclarion's Debt to Equity stood at -$0.17 in 2023, then surged by 107.34% to $0.01 in 2024, then slumped by 99.96% to $0.0 in 2025, then sank by 53.35% to $0.0 in 2026.
The last three Debt to Equity figures came in at $0.0 (Q1 2026), $0.0 (Q4 2025), and $0.01 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	-
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	1.26
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	0.46
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	-
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	0.37
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	-
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	-
10	Aclarion	-	-	3,750.00	0.00

Download Data